表紙
市場調査レポート

MediPoint:診断用X線画像装置 - EU市場の分析と予測

MediPoint: Diagnostic X-ray Imaging - EU Analysis and Market Forecasts

発行 GlobalData 商品コード 307783
出版日 ページ情報 英文 207 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.06円で換算しております。
Back to Top
MediPoint:診断用X線画像装置 - EU市場の分析と予測 MediPoint: Diagnostic X-ray Imaging - EU Analysis and Market Forecasts
出版日: 2014年07月07日 ページ情報: 英文 207 Pages
概要

疾病の早期診断は、生存率を高めるのに不可欠です。診断用X線画像装置は、成人や小児患者の早期発見や臨床的評価を達成するのに幅広く利用される技術で、疾病管理の基礎となっています。

当レポートでは、EU5ヶ国(フランス、ドイツ、イタリア、スペイン、英国)の診断用X線画像装置市場について調査分析し、産業の概要、競合評価、アンメットニーズ、パイプライン製品について検証し、主要企業プロファイル、市場の見通しなどについて、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

第3章 産業の概要

  • 診断用X線画像装置の原理
  • システムの概要
  • 操作の概要
  • X線画像装置の応用
  • 診断用X線画像装置の利点と欠点
  • 市場参入
  • ブランドロイヤルティ
  • 規制プロセス
  • 現在の償還の動向
  • 処置の動向
  • M&A、主なパートナーシップ

第4章 アンメットニーズ分析

  • 概要
  • 製品改良
  • 標準化の欠如
  • コスト抑制の必要性

第5章 市場機会分析

  • 近い将来には小型化

第6章 市場促進要因と機会

  • 概要
  • 促進要因
  • 障壁

第7章 競合評価

  • 概要
  • 検出器技術の進化
  • アナログのX線診断システム
  • デジタルのX線診断システム
  • CR vs. DR
  • 主な製品プロファイル

第8章 パイプライン評価

  • 概要
  • Appropriate Digital X-ray Imaging System(EssentialMed)
  • MODIS X-ray System(Tribogenics)
  • Flat-Panel Source-Based Portable X-ray Device(Radius Diagnostics)
  • Diffraction Enhanced Medical Imaging System(NextRay)
  • X-ray Imaging Device(Massachusetts Institute of Technology)
  • TBView 1000(University of Waterloo)

第9章 現在/将来の主要企業

  • 概要
  • 企業戦略の動向
  • 上位企業
  • 企業プロファイル(概要、ポートフォリオ、SWOT分析)
    • Agfa Healthcare
    • キヤノン
    • Carestream Health
    • 富士フイルムホールディングス
    • GE Healthcare
    • 日立メディコ
    • コニカミノルタ
    • Mindray Medical International
    • Philips Healthcare
    • Samsung Electronics
    • 島津製作所
    • Siemens Healthcare
    • Swissray International
    • 東芝メディカルシステムズ
    • その他の企業

第10章 市場の見通し

  • 企業の市場シェア
  • 市場区分別
  • 地域別

第11章 付録

図表

目次
Product Code: GDME1113CFR

An early diagnosis of disease is the foundation for increasing survival rates. Diagnostic X-ray imaging is the most widely used technique to achieve early detection and clinical assessment of adult and pediatric patients alike, making it a cornerstone of disease control. This report provides an analysis of the diagnostic X-ray imaging market in the US, the 5EU (France, Germany, Italy, Spain, and the UK), and some of the Asia-Pacific (APAC) regions (Australia, China, India, and Japan), and identifies the unmet needs in this diagnostic X-ray systems market. This report also discusses physician attitudes towards the utilization and perception of different types of X-ray imaging techniques, and the future of diagnostic X-ray imaging in the face of rapid technological advancements and other advanced imaging modalities.

According to GlobalData's estimates, Philips Healthcare, GE Healthcare, and Siemens Healthcare together accounted for over 60% of the market share within the EU diagnostic X-ray imaging market in 2012. This is mainly attributed to these companies' geographical and product portfolio diversity. They are all a part of large conglomerates with robust financial resources to invest in inorganic growth and R&D; therefore, these players have a significant market share.

Scope

  • An overview of Diagnostic X-Ray Imaging, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
  • Annualized the EU Diagnostic X-Ray Imaging market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
  • Investigation of current and future market competition for Diagnostic X-Ray Imaging.
  • Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
  • Competitor assessment including device approval analysis and device sales forecasts.
  • Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
  • Analysis of unmet needs within the market and opportunities for future players.
  • Technology trends evaluation to assess strength of pipeline.
  • An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
  • Company profiles including business description, financial overview and SWOT analysis.
  • Coverage of key market players.
  • Strategic assessment of the Diagnostic X-Ray Imaging sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as doctors.

Reasons to buy

  • Understand the trends shaping and driving the EU Diagnostic X-Ray Imaging market.
  • Realize device preferences of physicians who have performed the tests already.
  • Access market sizing, forecasts and quantified growth opportunities in the EU Diagnostic X-Ray Imaging market through 2018.
  • Quantify candidate patient populations to better design product pricing & launch plans.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
  • Perform benchmarking analysis of growth opportunities against currently marketed products.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
  • What's the next big thing in the EU Diagnostic X-Ray Imaging market landscape? Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Principle of Diagnostic X-ray Imaging
  • 3.2. System Overview
  • 3.3. Operation Overview
  • 3.4. Applications of X-ray Imaging
    • 3.4.1. Overview
    • 3.4.2. Chest Radiography
    • 3.4.3. Skeletal Defects and Pathology
    • 3.4.4. Abdominal and Gastrointestinal Examinations
  • 3.5. Advantages and Disadvantages of Diagnostic X-ray Imaging
    • 3.5.1. Overview

3.5.2. SWOT Analysis

  • 3.6. Market Access
    • 3.6.1. Product Life Cycle
    • 3.6.2. Purchasing Decisions
  • 3.7. Brand Loyalty
  • 3.8. Regulatory Process
  • 3.9. Current Reimbursement Trends
    • 3.9.1. France
    • 3.9.2. Germany
    • 3.9.3. Italy
    • 3.9.4. Spain
    • 3.9.5. UK
  • 3.10. Procedure Trends
    • 3.10.1. Overview
    • 3.10.2. 5EU
  • 3.11. Mergers and Acquisitions, Key Partnerships

4. Unmet Needs Analysis

  • 4.1. Overview
  • 4.2. Product Improvement
  • 4.3. Lack of Standardization
  • 4.4. Need for Cost-Containment

5. Market Opportunity Analysis

  • 5.1. Lighter X-ray Imaging Systems on the Horizon

6. Market Drivers and Barriers

  • 6.1. Overview
  • 6.2. Driver: Rising Prevalence of Diseases and Aging Population
    • 6.2.1. Sports-Related Injuries
    • 6.2.2. Trauma
    • 6.2.3. Smoking
    • 6.2.4. Aging
  • 6.3. Driver: Escalating Population
  • 6.4. Driver: Increased Demand for Cost-Effective Quality Healthcare
  • 6.5. Driver: Implementation of PACS/RIS to Drive Growth in Digital X-ray Imaging
  • 6.6. Driver: Increased Patient Awareness Regarding Excessive Radiation Dose Associated with CT Imaging
  • 6.7. Driver: Digital Tomosynthesis Unlocks New Frontiers for X-ray Imaging
  • 6.8. Driver: Sustained Monitoring Applications Using Diagnostic X-ray Imaging
  • 6.9. Driver: Digital Mobile Radiography Systems
  • 6.10. Barrier: Growth of X-ray Examinations is Inhibited by Advanced Imaging Modalities
  • 6.11. Barrier: Shortage of Radiologists
  • 6.12. Barrier: Lack of Enthusiasm Surrounding X-ray Imaging, and Shrinking Radiology Training
  • 6.13. Barrier: Lifestyle-Related Diseases Negatively Impact the Use of X-ray Imaging
  • 6.14. Barrier: Reduced Hospital Budgets
  • 6.15. Barrier: Refurbished Equipment Sales
  • 6.16. Barrier: Medical Device Excise Tax
  • 6.17. Barrier: Hospital Consolidation

7. Competitive Assessment

  • 7.1. Overview
  • 7.2. Evolution of Detector Technology
  • 7.3. Analog X-ray Systems
    • 7.3.1. Overview
    • 7.3.2. SWOT Analysis
  • 7.4. Digital X-ray Systems
    • 7.4.1. Overview
    • 7.4.2. CR X-ray Systems
    • 7.4.3. DR X-ray Systems
  • 7.5. CR Versus DR
  • 7.6. Key Product Profiles
    • 7.6.1. AeroDR X70 (Konica Minolta)
    • 7.6.2. FCR Profect One Plus/CS Plus (Fujifilm Holdings)
    • 7.6.3. ddRFormula (Swissray International)
    • 7.6.4. DigitalDiagnost (Philips Healthcare)
    • 7.6.5. Digix (Allengers Medical Systems)
    • 7.6.6. DirectView (Carestream Health)
    • 7.6.7. Discovery XR656 (GE Healthcare)
    • 7.6.8. DX-D 100 (Agfa Healthcare)
    • 7.6.9. Mobilett XP (Siemens Healthcare)
    • 7.6.10. Proteus XR/a (GE Healthcare)
    • 7.6.11. Radrex-i (Toshiba Medical Systems)
    • 7.6.12. Ysio (Siemens Healthcare)

8. Pipeline Assessment

  • 8.1. Overview
  • 8.2. Appropriate Digital X-ray Imaging System (EssentialMed)
    • 8.2.1. Overview
    • 8.2.2. SWOT Analysis
  • 8.3. MODIS X-ray System (Tribogenics)
    • 8.3.1. Overview
    • 8.3.2. SWOT Analysis
  • 8.4. Flat-Panel Source-Based Portable X-ray Device (Radius Diagnostics)
    • 8.4.1. Overview
    • 8.4.2. SWOT Analysis
  • 8.5. Diffraction Enhanced Medical Imaging System (NextRay)
    • 8.5.1. Overview
    • 8.5.2. SWOT Analysis
  • 8.6. X-ray Imaging Device (Massachusetts Institute of Technology)
    • 8.6.1. Overview
    • 8.6.2. SWOT Analysis
  • 8.7. TBView 1000 (University of Waterloo)
    • 8.7.1. Overview
    • 8.7.2. SWOT Analysis

9. Current and Future Players

  • 9.1. Overview
  • 9.2. Trends in Corporate Strategy
  • 9.3. Who Is on Top?
  • 9.4. Agfa Healthcare
    • 9.4.1. Overview
    • 9.4.2. Portfolio Assessment
    • 9.4.3. SWOT Analysis
  • 9.5. Allengers Medical Systems
    • 9.5.1. Overview
    • 9.5.2. Portfolio Assessment
    • 9.5.3. SWOT Analysis
  • 9.6. Canon
    • 9.6.1. Overview
    • 9.6.2. Portfolio Assessment
    • 9.6.3. SWOT Analysis
  • 9.7. Carestream Health
    • 9.7.1. Overview
    • 9.7.2. Portfolio Assessment
    • 9.7.3. SWOT Analysis
  • 9.8. China Resources Wandong Medical Equipment
    • 9.8.1. Overview
    • 9.8.2. Portfolio Assessment
    • 9.8.3. SWOT Analysis
  • 9.9. Fujifilm Holdings
    • 9.9.1. Overview
    • 9.9.2. Portfolio Assessment
    • 9.9.3. SWOT Analysis
  • 9.10. GE Healthcare
    • 9.10.1. Overview
    • 9.10.2. Portfolio Assessment
    • 9.10.3. SWOT Analysis
  • 9.11. General Medical Merate
    • 9.11.1. Overview
    • 9.11.2. Portfolio Assessment
    • 9.11.3. SWOT Analysis
  • 9.12. Hitachi Medical
    • 9.12.1. Overview
    • 9.12.2. Portfolio Assessment
    • 9.12.3. SWOT Analysis
  • 9.13. Konica Minolta
    • 9.13.1. Overview
    • 9.13.2. Portfolio Assessment
    • 9.13.3. SWOT Analysis
  • 9.14. Mindray Medical International
    • 9.14.1. Overview
    • 9.14.2. Portfolio Assessment
    • 9.14.3. SWOT Analysis
  • 9.15. Neusoft Medical
    • 9.15.1. Overview
    • 9.15.2. Portfolio Assessment
    • 9.15.3. SWOT Analysis
  • 9.16. Philips Healthcare
    • 9.16.1. Overview
    • 9.16.2. Portfolio Assessment
    • 9.16.3. SWOT Analysis
  • 9.17. Samsung Electronics
    • 9.17.1. Overview
    • 9.17.2. Portfolio Assessment
    • 9.17.3. SWOT Analysis
  • 9.18. Shimadzu Corporation
    • 9.18.1. Overview
    • 9.18.2. Portfolio Assessment
    • 9.18.3. SWOT Analysis
  • 9.19. Siemens Healthcare
    • 9.19.1. Overview
    • 9.19.2. Portfolio Assessment
    • 9.19.3. SWOT Analysis
  • 9.20. Swissray International
    • 9.20.1. Overview
    • 9.20.2. Portfolio Assessment
    • 9.20.3. SWOT Analysis
  • 9.21. Toshiba Medical Systems
    • 9.21.1. Overview
    • 9.21.2. Portfolio Assessment
    • 9.21.3. SWOT Analysis
  • 9.22. Other Companies

10. Market Outlook

  • 10.1. Company Market Share
    • 10.1.1. EU
    • 10.1.2. France
    • 10.1.3. Germany
    • 10.1.4. Italy
    • 10.1.5. Spain
    • 10.1.6. UK
  • 10.2. By Market Segment
    • 10.2.1. Overview
    • 10.2.2. Analog X-ray Systems
    • 10.2.3. Retrofit X-ray Systems
    • 10.2.4. CR X-ray Systems
    • 10.2.5. DR X-ray Systems
  • 10.3. By Geography
    • 10.3.1. EU Overview
    • 10.3.2. France
    • 10.3.3. Germany
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. UK

11. Appendix

  • 11.1. Bibliography
  • 11.2. Definitions
  • 11.3. Abbreviations
  • 11.4. Research Methodology
    • 11.4.1. Overview
    • 11.4.2. Coverage
    • 11.4.3. Secondary Research
  • 11.5. Physicians and Specialists Included in this Study
  • 11.6. Primary Research
    • 11.6.1. Primary Research - Key Opinion Leader Interviews
    • 11.6.2. Expert Panel Validation
    • 11.6.3. Stakeholder Survey
  • 11.7. Forecasting Methodology
  • 11.8. About the Authors
    • 11.8.1. Analysts
    • 11.8.2. Global Head of Healthcare
  • 11.9. About GlobalData
  • 11.10. Disclaimer

List of Tables

  • Table 1: Advantages and Disadvantages of X-ray Imaging, 2014
  • Table 2: Diagnostic X-ray Imaging SWOT Analysis, 2014
  • Table 3: Average Product Life Cycle of X-ray Systems
  • Table 4: Recent Key Events in the Diagnostic X-ray Imaging Market
  • Table 5: Product Improvement Strategies
  • Table 6: Equipment Cost-Reduction Strategies
  • Table 7: Diagnostic X-ray Imaging Market - Drivers and Barriers, 2014
  • Table 8: Analog X-ray Systems
  • Table 9: Analog X-ray Systems SWOT Analysis, 2014
  • Table 10: CR X-ray Systems
  • Table 11: CR X-ray Systems SWOT Analysis, 2014
  • Table 12: DR X-ray Systems
  • Table 13: DR X-ray Systems SWOT Analysis, 2014
  • Table 14: Comparison of CR and DR X-ray Technology
  • Table 15: AeroDR X70 Product Profile, 2014
  • Table 16: AeroDR X70 SWOT Analysis, 2014
  • Table 17: FCR Profect One Plus/CS Plus Product Profile, 2014
  • Table 18: FCR Profect One Plus/CS Plus SWOT Analysis, 2014
  • Table 19: ddRFormula Product Profile, 2014
  • Table 20: ddRFormula SWOT Analysis, 2014
  • Table 21: DigitalDiagnost Product Profile, 2014
  • Table 22: DigitalDiagnost SWOT Analysis, 2014
  • Table 23: Digix Product Profile, 2014
  • Table 24: Digix SWOT Analysis, 2014
  • Table 25: DirectView Product Profile, 2014
  • Table 26: DirectView SWOT Analysis, 2014
  • Table 27: Discovery XR656 Product Profile, 2014
  • Table 28: Discovery XR656 SWOT Analysis, 2014
  • Table 29: DX-D 100 Product Profile, 2014
  • Table 30: DX-D 100 SWOT Analysis, 2014
  • Table 31: Mobilett XP Product Profile, 2014
  • Table 32: Mobilett XP SWOT Analysis, 2014
  • Table 33: Proteus XR/a Product Profile
  • Table 34: Proteus XR/a SWOT Analysis, 2013
  • Table 35: Radrex-i Product Profile
  • Table 36: Radrex-i SWOT Analysis, 2014
  • Table 37: Ysio Product Profile, 2014
  • Table 38: Ysio SWOT Analysis, 2014
  • Table 39: Appropriate Digital X-ray Imaging System SWOT Analysis, 2014
  • Table 40: MODIS X-ray System SWOT Analysis, 2014
  • Table 41: Flat-Panel Source-Based Portable X-ray Device SWOT Analysis, 2014
  • Table 42: Diffraction Enhanced Medical Imaging System SWOT Analysis, 2014
  • Table 43: X-ray Imaging Device SWOT Analysis, 2014
  • Table 44: TBView 1000 SWOT Analysis, 2014
  • Table 45: Agfa Healthcare SWOT Analysis, 2014
  • Table 46: Allengers Medical Systems SWOT Analysis, 2014
  • Table 47: Canon SWOT Analysis, 2014
  • Table 48: Carestream Health SWOT Analysis, 2014
  • Table 49: CR Wandong Medical Equipment SWOT Analysis, 2014
  • Table 50: Fujifilm Holdings SWOT Analysis, 2014
  • Table 51: GE Healthcare SWOT Analysis, 2014
  • Table 52: General Medical Merate SWOT Analysis, 2014
  • Table 53: Hitachi Medical SWOT Analysis, 2014
  • Table 54: Konica Minolta SWOT Analysis, 2014
  • Table 55: Mindray Medical International SWOT Analysis, 2014
  • Table 56: Neusoft Medical SWOT Analysis, 2014
  • Table 57: Philips Healthcare SWOT Analysis, 2014
  • Table 58: Samsung Electronics SWOT Analysis, 2014
  • Table 59: Shimadzu Corporation SWOT Analysis, 2014
  • Table 60: Siemens Healthcare SWOT Analysis, 2014
  • Table 61: Swissray International SWOT Analysis, 2014
  • Table 62: Toshiba Medical Systems SWOT Analysis, 2014
  • Table 63: Other Companies in the Diagnostic X-ray Imaging Market, 2014
  • Table 64: Diagnostic X-ray Imaging, Company Market Share, EU, 2012
  • Table 65: Diagnostic X-ray Imaging, Company Market Share, France, 2012
  • Table 66: Diagnostic X-ray Imaging, Company Market Share, Germany, 2012
  • Table 67: Diagnostic X-ray Imaging, Company Market Share, Italy, 2012
  • Table 68: Diagnostic X-ray Imaging, Company Market Share, Spain, 2012
  • Table 69: Diagnostic X-ray Imaging, Company Market Share, UK, 2012
  • Table 70: 5EU Diagnostic X-ray Systems Sales ($m), by Market Segment, 2011-2020
  • Table 71: 5EU Diagnostic X-ray Systems Sales ($m), Analog X-ray Systems, 2011-2020
  • Table 72: 5EU Diagnostic X-ray Systems Sales ($m), Retrofit X-ray Systems, 2011-2020
  • Table 73: 5EU Diagnostic X-ray Systems Sales ($m), CR X-ray Systems, 2011-2020
  • Table 74: 5EU Diagnostic X-ray Systems Sales ($m), DR X-ray Systems, 2011-2020
  • Table 75: 5EU Diagnostic X-ray Systems Sales ($m), by Geography, 2011-2020
  • Table 76: Total Unit Sales of Diagnostic X-ray Systems, 5EU, 2011-2020
  • Table 77: France Diagnostic X-ray Systems Sales ($m), by Segment, 2011-2020
  • Table 78: Total Unit Sales of Diagnostic X-ray Systems, France, 2011-2020
  • Table 79: Change in ASP of Diagnostic X-ray Imaging Systems, France, 2011-2020
  • Table 80: Germany Diagnostic X-ray Systems Sales ($m), by Segment, 2011-2020
  • Table 81: Total Unit Sales of Diagnostic X-ray Systems, Germany, 2011-2020
  • Table 82: Change in ASP of Diagnostic X-ray Imaging Systems, Germany, 2011-2020
  • Table 83: Italy Diagnostic X-ray Systems Sales ($m), by Segment, 2011-2020
  • Table 84: Total Unit Sales of Diagnostic X-ray Systems, Italy, 2011-2020
  • Table 85: Change in ASP of Diagnostic X-ray Systems, Italy, 2011-2020
  • Table 86: Spain Diagnostic X-ray Systems Sales ($m), by Segment, 2011-2020
  • Table 87: Total Unit Sales of Diagnostic X-ray Systems, Spain, 2011-2020
  • Table 88: Change in ASP Price of Diagnostic X-ray Systems, Spain, 2011-2020
  • Table 89: UK Diagnostic X-ray Systems Sales ($m), by Segment, 2011-2020
  • Table 90: Total Unit Sales of Diagnostic X-ray Systems, UK, 2011-2020
  • Table 91: Change in ASP of Diagnostic X-ray Systems, UK, 2011-2020
  • Table 92: Primary Research Summary
  • Table 93: Primary Research Participants' Professional Affiliation

List of Figures

  • Figure 1: Electromagnetic Spectrum
  • Figure 2: X-ray Scan of the Ankle
  • Figure 3: Operation of X-ray Imaging
  • Figure 4: Evolution of Detector Technology
  • Figure 5: Types of Digital Detectors
  • Figure 6: Diagnostic X-ray Imaging, Company Market Share, EU, 2012
  • Figure 7: Diagnostic X-ray Imaging, Company Market Share, France, 2012
  • Figure 8: Diagnostic X-ray Imaging, Company Market Share, Germany, 2012
  • Figure 9: Diagnostic X-ray Imaging, Company Market Share, Italy, 2012
  • Figure 10: Diagnostic X-ray Imaging, Company Market Share, Spain, 2012
  • Figure 11: Diagnostic X-ray Imaging, Company Market Share, UK, 2012
  • Figure 12: 5EU Diagnostic X-ray Systems Sales ($m), by Market Segment, 2011-2020
  • Figure 13: 5EU Overall Sales ($m), Analog X-ray Systems, 2011-2020
  • Figure 14: 5EU Overall Sales ($m), Retrofit X-ray Systems, 2011-2020
  • Figure 15: 5EU Overall Sales ($m), CR X-ray Systems, 2011-2020
  • Figure 16: 5EU Overall Sales ($m), DR X-ray Systems, 2011-2020
  • Figure 17: 5EU Overall Sales ($m), Diagnostic X-ray Systems, 2011-2020
  • Figure 18: Total Unit Sales of Diagnostic X-ray Systems, 5EU, 2011-2020
  • Figure 19: 5EU Sales Forecast for Diagnostic X-ray Systems, by Geography, 2013 and 2020
  • Figure 20: France Overall Sales ($m), Diagnostic X-ray Systems, 2011-2020
  • Figure 21: Total Unit Sales of Diagnostic X-ray Systems, France, 2011-2020
  • Figure 22: France Sales Forecast ($m) for Diagnostic X-ray Systems, by Segment, 2013 and 2020
  • Figure 23: Change in ASP of Diagnostic X-ray Imaging Systems, France, 2011-2020
  • Figure 24: Germany Diagnostic X-ray Systems Sales ($m), by Segment, 2011-2020
  • Figure 25: Total Unit Sales of Diagnostic X-ray Systems, Germany, 2011-2020
  • Figure 26: Germany Sales Forecast ($m) for Diagnostic X-ray Systems, by Segment, 2013 and 2020
  • Figure 27: Change in ASP of Diagnostic X-ray Systems, Germany, 2011-2020
  • Figure 28: Italy Overall Sales ($m) for Diagnostic X-ray Systems, 2011-2020
  • Figure 29: Total Unit Sales of Diagnostic X-ray Systems, Italy, 2011-2020
  • Figure 30: Italy Sales Forecast ($m) for Diagnostic X-ray Systems, by Segment, 2013 and 2020
  • Figure 31: Change in ASP of Diagnostic X-ray Systems, Italy, 2011-2020
  • Figure 32: Spain Overall Sales ($m) for Diagnostic X-ray Systems, 2011-2020
  • Figure 33: Total Unit Sales of Diagnostic X-ray Systems, Spain, 2011-2020
  • Figure 34: Spain Sales ($m) Forecast ($m) for Diagnostic X-ray Systems, by Segment, 2013 and 2020
  • Figure 35: Decline in ASP of Diagnostic X-ray Systems, Spain, 2011-2020
  • Figure 36: UK Overall Sales ($m) for Diagnostic X-ray Systems, 2011-2020
  • Figure 37: Total Unit Sales of Diagnostic X-ray Systems, UK, 2011-2020
  • Figure 38: UK Sales Forecast ($m) for Diagnostic X-ray Systems, by Segment, 2013 and 2020
  • Figure 39: Change in ASP of Diagnostic X-ray Systems, UK, 2011-2020
  • Figure 40: Primary Research Summary
  • Figure 41: Primary Research Participants' Professional Affiliation
Back to Top